Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients

Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients

(2013) S. Gueller et al.   Transplant Infectious Disease

Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus

(2012) Hans H. Hirsch et al.   CLINICAL INFECTIOUS DISEASES

Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation

(2012) Lily Li et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Ribavirin Plasma Concentration Measurements in Patients With Hepatitis C: Early Ribavirin Concentrations Predict Steady-State Concentrations

(2010) Serena Slavenburg et al.   THERAPEUTIC DRUG MONITORING

RNA Respiratory Viral Infections in Solid Organ Transplant Recipients

(2009) M. G. Ison et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Efficacy of Oral Ribavirin in Lung Transplant Patients With Respiratory Syncytial Virus Lower Respiratory Tract Infection

(2009) Andres Pelaez et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients

(2009) V. Liu et al.   Transplant Infectious Disease

Respiratory Syncytial Virus Infection in Recipients of Allogeneic Stem-Cell Transplantation: A Retrospective Study of the Incidence, Clinical Features, and Outcome

(2009) Gayane Avetisyan et al.   TRANSPLANTATION

Respiratory Syncytial Virus Infection in Patients with Hematological Diseases: Single-Center Study and Review of the Literature

(2007) N. Khanna et al.   CLINICAL INFECTIOUS DISEASES